Our research focuses on the molecular correlates of treatment response to rapid acting antidepressants with particular emphasis on ketamine and psilocybin. We are also interested in the regulatory mechanisms controlling the trafficking and function of the sortilin receptor in health and disease states.
Current research activities are targeted into three major focus areas:
We aim to discover molecular targets and mechanisms that can be translated into novel therapeutic strategies for neuropsychiatric and neurodegenerative disorders.
We have projects available for Master, PhD, and Research Year students. The projects are particularly relevant for students with a background in molecular biology, molecular medicine, medicinal chemistry or medicine. We support collaborative projects within our unit as well as collaborations with external groups.
Please contact Heidi Kaastrup Müller (firstname.lastname@example.org) for further information.